XACIG(SH:600596)2022-10-30 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥4,785,469,756.35, a decrease of 0.33% compared to the same period last year[7]. - The net profit attributable to shareholders for the same period was ¥533,737,838.86, down 29.44% year-on-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥552,889,210.71, a decrease of 27.29% compared to the previous year[7]. - The basic earnings per share for Q3 2022 was ¥0.4658, reflecting a decline of 29.43% year-on-year[9]. - Total operating revenue for Q3 2022 reached ¥18,128,757,688.97, an increase of 36.5% compared to ¥13,316,269,620.98 in the same period of 2021[33]. - Net profit attributable to shareholders of the parent company for Q3 2022 was ¥2,867,248,244.29, compared to ¥1,601,055,408.98 in Q3 2021, reflecting a growth of 79.0%[36]. - Total comprehensive income for the period attributable to the parent company's owners reached CNY 2,936,643,813.16, a significant increase from CNY 1,599,918,444.43 in the same period last year, representing an 83.6% growth[39]. - Basic and diluted earnings per share increased to CNY 2.5025, compared to CNY 1.3973 in the previous year, reflecting an increase of 79.4%[39]. Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥19,890,900,097.22, representing a 15.65% increase from the end of the previous year[9]. - The total assets as of Q3 2022 amounted to ¥19,890,900,097.22, a significant increase from ¥17,199,341,506.91 in the previous year[30]. - The total liabilities for Q3 2022 were ¥7,417,041,706.38, slightly up from ¥7,364,208,881.77 year-over-year[30]. - The company's total equity increased to ¥12,473,858,390.84, up from ¥9,835,132,625.14 in Q3 2021, reflecting strong retained earnings and capital growth[30]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥2,507,980,200.31, an increase of 65.10% year-on-year[7]. - Cash flow from operating activities generated a net amount of CNY 2,507,980,200.31, up from CNY 1,519,108,009.10, marking a 64.8% increase year-over-year[43]. - Cash inflow from sales of goods and services amounted to CNY 13,446,152,876.06, compared to CNY 9,357,193,907.20 in the previous year, indicating a growth of 43.5%[43]. - Total cash and cash equivalents at the end of the period reached CNY 3,927,606,433.52, up from CNY 1,901,354,182.37, representing a 106.5% increase[45]. - The company received CNY 332,816,256.76 in tax refunds, an increase from CNY 175,608,141.85 in the previous year, representing an increase of 89.6%[43]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 136,869[19]. - The largest shareholder, Chuanhua Group Co., Ltd., holds 142,416,120 shares, accounting for 12.43% of the total shares[19]. - The total number of shares held by the top ten shareholders includes significant stakes from Chuanhua Group and Zhejiang Chuanhua Chemical Group Co., Ltd.[19]. Research and Development - Research and development expenses increased to ¥556,027,922.57 in Q3 2022, up 65.5% from ¥335,758,412.51 in the same quarter of 2021[33]. Inventory and Receivables - Accounts receivable increased to ¥1,657,143,598.71 from ¥1,420,160,350.35 year-over-year[25]. - Inventory decreased to ¥2,492,624,171.67 from ¥2,940,407,249.91 year-over-year[25]. - Total current assets increased to ¥10,592,891,081.34 from ¥8,958,044,603.33 year-over-year[25]. - The company's long-term equity investments rose to ¥1,250,095,828.71 from ¥1,126,261,892.20 year-over-year[25]. Strategic Developments - The company has not disclosed any significant new strategies or product developments during the reporting period[22]. - There are no known related party transactions among the other shareholders, except for the relationship between Chuanhua Group and Zhejiang Chuanhua Chemical[21].